Review



recombinant human hbegf  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    R&D Systems recombinant human hbegf
    FIGURE 3 | MPS induced perturbations similar to those resulting from AREG inhibition. (a) A bar chart showing the TPM levels of seven known EGFR-ligands in untreated monolayer-cultured keratinocytes. Data represent the mean ± SD (n = 3). (b) A bar chart showing the first principal component value from PCA of bulk RNA-seq data from keratinocytes, subjected to various treatments for 24 h: 50 μg/mL of AREG antibody (AREG_Ab), 300 ng/ mL of AREG, 30 μg/mL of MPS, or a combination of AREG and MPS. Data represent the mean ± SD (n = 3). *p < 0.05 versus untreated control (Dunnett's multiple comparison test), #p < 0.05 versus AREG-treated (Aspin-Welch's t-test). (c) A heatmap showing the expression of 4150 DEGs from the monolayer culture experiment (Figure 1) in keratinocytes subjected to the aforementioned treatments. The colour scale represents the scaled expression of each gene. (d) Enrichment plots from GSEA of DEGs in keratinocytes treated with AREG antibody, compared to untreated controls. Top 200 upregulated or downregulated genes from the monolayer culture experiment (Figure 1) were utilised as gene sets. P denotes p value, NES denotes the normalised enrichment score. (e) Relative expression of representative genes in keratinocytes, as determined by real-time qPCR. These keratinocytes were treated with MPS at concentrations ranging from 3 to 300 μg/mL for 24 h, or untreated, in the presence of various EGFR-ligands. The concentrations of the EGFR- ligands were as follows: EGF at 3 ng/mL, <t>HBEGF</t> at 10 ng/mL, AREG at 300 ng/mL, and EPGN at 1000 ng/mL. Data represent the mean ± SD (n = 3). DEG, differentially expressed gene; GSEA, gene set enrichment analysis; MPS, mucopolysacccharide polyphosphate; TPM, transcripts per million.
    Recombinant Human Hbegf, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 142 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+hbegf/Recombinant+Human+HB-EGF+Protein/pm39422315-44-52-55
    Average 93 stars, based on 142 article reviews
    recombinant human hbegf - by Bioz Stars, 2026-09
    93/100 stars

    Images

    1) Product Images from "Pharmacological Impacts of Mucopolysacccharide Polyphosphates in the Epidermis Involves Inhibition of Amphiregulin-Mediated Signals in Keratinocytes."

    Article Title: Pharmacological Impacts of Mucopolysacccharide Polyphosphates in the Epidermis Involves Inhibition of Amphiregulin-Mediated Signals in Keratinocytes.

    Journal: Experimental dermatology

    doi: 10.1111/exd.70000

    FIGURE 3 | MPS induced perturbations similar to those resulting from AREG inhibition. (a) A bar chart showing the TPM levels of seven known EGFR-ligands in untreated monolayer-cultured keratinocytes. Data represent the mean ± SD (n = 3). (b) A bar chart showing the first principal component value from PCA of bulk RNA-seq data from keratinocytes, subjected to various treatments for 24 h: 50 μg/mL of AREG antibody (AREG_Ab), 300 ng/ mL of AREG, 30 μg/mL of MPS, or a combination of AREG and MPS. Data represent the mean ± SD (n = 3). *p < 0.05 versus untreated control (Dunnett's multiple comparison test), #p < 0.05 versus AREG-treated (Aspin-Welch's t-test). (c) A heatmap showing the expression of 4150 DEGs from the monolayer culture experiment (Figure 1) in keratinocytes subjected to the aforementioned treatments. The colour scale represents the scaled expression of each gene. (d) Enrichment plots from GSEA of DEGs in keratinocytes treated with AREG antibody, compared to untreated controls. Top 200 upregulated or downregulated genes from the monolayer culture experiment (Figure 1) were utilised as gene sets. P denotes p value, NES denotes the normalised enrichment score. (e) Relative expression of representative genes in keratinocytes, as determined by real-time qPCR. These keratinocytes were treated with MPS at concentrations ranging from 3 to 300 μg/mL for 24 h, or untreated, in the presence of various EGFR-ligands. The concentrations of the EGFR- ligands were as follows: EGF at 3 ng/mL, HBEGF at 10 ng/mL, AREG at 300 ng/mL, and EPGN at 1000 ng/mL. Data represent the mean ± SD (n = 3). DEG, differentially expressed gene; GSEA, gene set enrichment analysis; MPS, mucopolysacccharide polyphosphate; TPM, transcripts per million.
    Figure Legend Snippet: FIGURE 3 | MPS induced perturbations similar to those resulting from AREG inhibition. (a) A bar chart showing the TPM levels of seven known EGFR-ligands in untreated monolayer-cultured keratinocytes. Data represent the mean ± SD (n = 3). (b) A bar chart showing the first principal component value from PCA of bulk RNA-seq data from keratinocytes, subjected to various treatments for 24 h: 50 μg/mL of AREG antibody (AREG_Ab), 300 ng/ mL of AREG, 30 μg/mL of MPS, or a combination of AREG and MPS. Data represent the mean ± SD (n = 3). *p < 0.05 versus untreated control (Dunnett's multiple comparison test), #p < 0.05 versus AREG-treated (Aspin-Welch's t-test). (c) A heatmap showing the expression of 4150 DEGs from the monolayer culture experiment (Figure 1) in keratinocytes subjected to the aforementioned treatments. The colour scale represents the scaled expression of each gene. (d) Enrichment plots from GSEA of DEGs in keratinocytes treated with AREG antibody, compared to untreated controls. Top 200 upregulated or downregulated genes from the monolayer culture experiment (Figure 1) were utilised as gene sets. P denotes p value, NES denotes the normalised enrichment score. (e) Relative expression of representative genes in keratinocytes, as determined by real-time qPCR. These keratinocytes were treated with MPS at concentrations ranging from 3 to 300 μg/mL for 24 h, or untreated, in the presence of various EGFR-ligands. The concentrations of the EGFR- ligands were as follows: EGF at 3 ng/mL, HBEGF at 10 ng/mL, AREG at 300 ng/mL, and EPGN at 1000 ng/mL. Data represent the mean ± SD (n = 3). DEG, differentially expressed gene; GSEA, gene set enrichment analysis; MPS, mucopolysacccharide polyphosphate; TPM, transcripts per million.

    Techniques Used: Inhibition, Cell Culture, RNA Sequencing, Control, Comparison, Expressing

    Related Articles

    Recombinant:

    Article Title: Arachidonate 12-Lipoxygenase Inhibitors Promote S100A3 Citrullination in Cultured SW480 Cells and Isolated Hair Follicles.
    Article Snippet: Commercially available 12S-hydroxyeicosatetraenoic acid (12S-HETE) and 12-hydroperoxyeicosatetraenoic acid (12-HPETE) solutions (Cayman) were condensed by evaporating ethanol with a nitrogen gas stream before use. .. Lyophilized recombinant HBEGF (R&D Systems, Minneapolis, MN, U.S.A.) was reconstituted with distilled water. ..

    Article Title: Diminished survival of human cytotrophoblast cells exposed to hypoxia/reoxygenation injury and associated reduction of heparin-binding EGF-like growth factor
    Article Snippet: .. Medium was supplemented with 1 nM recombinant HBEGF (R&D Systems, Minneapolis, MN), 10 μg/ml mouse anti-HER1 (Ab-2) or HER4 (Ab-3) blocking antibodies (LabVision, Fremont, CA), 20 μg/ml mouse non-immune IgG (Jackson ImmunoResearch Laboratories, West Grove, PA), 20 μg/ml of the capase inhibitors, Z-DEVD-FMK, Z-VAD-FMK or 200 ug/ml of the negative control Z-FA-FMK (EMD Biosciences), or 2 mM H 2 O 2 (Sigma). .. Cytotrophoblast cells grown in 150 μl of medium in 96-well tissue culture plates (Becton Dickinson) were processed for immunohistochemistry, as previously described( 13 )Nuclei expressing Ki-67 were labeled with a monoclonal antibody (Ki-S5; DAKO, Carpinteria, CA).

    Blocking Assay:

    Article Title: Diminished survival of human cytotrophoblast cells exposed to hypoxia/reoxygenation injury and associated reduction of heparin-binding EGF-like growth factor
    Article Snippet: .. Medium was supplemented with 1 nM recombinant HBEGF (R&D Systems, Minneapolis, MN), 10 μg/ml mouse anti-HER1 (Ab-2) or HER4 (Ab-3) blocking antibodies (LabVision, Fremont, CA), 20 μg/ml mouse non-immune IgG (Jackson ImmunoResearch Laboratories, West Grove, PA), 20 μg/ml of the capase inhibitors, Z-DEVD-FMK, Z-VAD-FMK or 200 ug/ml of the negative control Z-FA-FMK (EMD Biosciences), or 2 mM H 2 O 2 (Sigma). .. Cytotrophoblast cells grown in 150 μl of medium in 96-well tissue culture plates (Becton Dickinson) were processed for immunohistochemistry, as previously described( 13 )Nuclei expressing Ki-67 were labeled with a monoclonal antibody (Ki-S5; DAKO, Carpinteria, CA).

    Negative Control:

    Article Title: Diminished survival of human cytotrophoblast cells exposed to hypoxia/reoxygenation injury and associated reduction of heparin-binding EGF-like growth factor
    Article Snippet: .. Medium was supplemented with 1 nM recombinant HBEGF (R&D Systems, Minneapolis, MN), 10 μg/ml mouse anti-HER1 (Ab-2) or HER4 (Ab-3) blocking antibodies (LabVision, Fremont, CA), 20 μg/ml mouse non-immune IgG (Jackson ImmunoResearch Laboratories, West Grove, PA), 20 μg/ml of the capase inhibitors, Z-DEVD-FMK, Z-VAD-FMK or 200 ug/ml of the negative control Z-FA-FMK (EMD Biosciences), or 2 mM H 2 O 2 (Sigma). .. Cytotrophoblast cells grown in 150 μl of medium in 96-well tissue culture plates (Becton Dickinson) were processed for immunohistochemistry, as previously described( 13 )Nuclei expressing Ki-67 were labeled with a monoclonal antibody (Ki-S5; DAKO, Carpinteria, CA).



    Similar Products

    94
    MedChemExpress agents 463 recombinant hbegf
    Agents 463 Recombinant Hbegf, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+hbegf/HB-EGF%2C+Mouse/pm41108076-217-27-31
    Average 94 stars, based on 1 article reviews
    agents 463 recombinant hbegf - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    90
    ProSpec human recombinant hbegf (cyt-119)
    Human Recombinant Hbegf (Cyt 119), supplied by ProSpec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+hbegf/human+recombinant+hbegf++cyt+119+/bio_rxiv__2023__01__01__522017-23-0-7
    Average 90 stars, based on 1 article reviews
    human recombinant hbegf (cyt-119) - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    95
    Bio-Techne corporation recombinant human hb-egf protein
    Recombinant Human Hb Egf Protein, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+hbegf/Recombinant+Human+HB-EGF+Protein/bio-techne+corporation___259-he
    Average 95 stars, based on 1 article reviews
    recombinant human hb-egf protein - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    94
    Bio-Techne corporation recombinant human hb-egf protein, cf
    Recombinant Human Hb Egf Protein, Cf, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+hbegf/Recombinant+Human+HB-EGF+Protein%2C+CF/bio-techne+corporation___259-he-cf
    Average 94 stars, based on 1 article reviews
    recombinant human hb-egf protein, cf - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    93
    R&D Systems recombinant human hbegf
    FIGURE 3 | MPS induced perturbations similar to those resulting from AREG inhibition. (a) A bar chart showing the TPM levels of seven known EGFR-ligands in untreated monolayer-cultured keratinocytes. Data represent the mean ± SD (n = 3). (b) A bar chart showing the first principal component value from PCA of bulk RNA-seq data from keratinocytes, subjected to various treatments for 24 h: 50 μg/mL of AREG antibody (AREG_Ab), 300 ng/ mL of AREG, 30 μg/mL of MPS, or a combination of AREG and MPS. Data represent the mean ± SD (n = 3). *p < 0.05 versus untreated control (Dunnett's multiple comparison test), #p < 0.05 versus AREG-treated (Aspin-Welch's t-test). (c) A heatmap showing the expression of 4150 DEGs from the monolayer culture experiment (Figure 1) in keratinocytes subjected to the aforementioned treatments. The colour scale represents the scaled expression of each gene. (d) Enrichment plots from GSEA of DEGs in keratinocytes treated with AREG antibody, compared to untreated controls. Top 200 upregulated or downregulated genes from the monolayer culture experiment (Figure 1) were utilised as gene sets. P denotes p value, NES denotes the normalised enrichment score. (e) Relative expression of representative genes in keratinocytes, as determined by real-time qPCR. These keratinocytes were treated with MPS at concentrations ranging from 3 to 300 μg/mL for 24 h, or untreated, in the presence of various EGFR-ligands. The concentrations of the EGFR- ligands were as follows: EGF at 3 ng/mL, <t>HBEGF</t> at 10 ng/mL, AREG at 300 ng/mL, and EPGN at 1000 ng/mL. Data represent the mean ± SD (n = 3). DEG, differentially expressed gene; GSEA, gene set enrichment analysis; MPS, mucopolysacccharide polyphosphate; TPM, transcripts per million.
    Recombinant Human Hbegf, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+hbegf/Recombinant+Human+HB-EGF+Protein/pm39422315-44-52-55
    Average 93 stars, based on 1 article reviews
    recombinant human hbegf - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    94
    MedChemExpress hbegf plus nrg1
    FIGURE 3 | MPS induced perturbations similar to those resulting from AREG inhibition. (a) A bar chart showing the TPM levels of seven known EGFR-ligands in untreated monolayer-cultured keratinocytes. Data represent the mean ± SD (n = 3). (b) A bar chart showing the first principal component value from PCA of bulk RNA-seq data from keratinocytes, subjected to various treatments for 24 h: 50 μg/mL of AREG antibody (AREG_Ab), 300 ng/ mL of AREG, 30 μg/mL of MPS, or a combination of AREG and MPS. Data represent the mean ± SD (n = 3). *p < 0.05 versus untreated control (Dunnett's multiple comparison test), #p < 0.05 versus AREG-treated (Aspin-Welch's t-test). (c) A heatmap showing the expression of 4150 DEGs from the monolayer culture experiment (Figure 1) in keratinocytes subjected to the aforementioned treatments. The colour scale represents the scaled expression of each gene. (d) Enrichment plots from GSEA of DEGs in keratinocytes treated with AREG antibody, compared to untreated controls. Top 200 upregulated or downregulated genes from the monolayer culture experiment (Figure 1) were utilised as gene sets. P denotes p value, NES denotes the normalised enrichment score. (e) Relative expression of representative genes in keratinocytes, as determined by real-time qPCR. These keratinocytes were treated with MPS at concentrations ranging from 3 to 300 μg/mL for 24 h, or untreated, in the presence of various EGFR-ligands. The concentrations of the EGFR- ligands were as follows: EGF at 3 ng/mL, <t>HBEGF</t> at 10 ng/mL, AREG at 300 ng/mL, and EPGN at 1000 ng/mL. Data represent the mean ± SD (n = 3). DEG, differentially expressed gene; GSEA, gene set enrichment analysis; MPS, mucopolysacccharide polyphosphate; TPM, transcripts per million.
    Hbegf Plus Nrg1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+hbegf/Recombinant+Human+Heregulin-1+beta1/lund_andrew_james__2024__lineage_biases_of_airway_submucosal_gland_derived_stem_progenitors_and_erbb_family_ligand_mediated-508-11-18
    Average 94 stars, based on 1 article reviews
    hbegf plus nrg1 - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    91
    OriGene heparinbinding egf like growth factor
    FIGURE 3 | MPS induced perturbations similar to those resulting from AREG inhibition. (a) A bar chart showing the TPM levels of seven known EGFR-ligands in untreated monolayer-cultured keratinocytes. Data represent the mean ± SD (n = 3). (b) A bar chart showing the first principal component value from PCA of bulk RNA-seq data from keratinocytes, subjected to various treatments for 24 h: 50 μg/mL of AREG antibody (AREG_Ab), 300 ng/ mL of AREG, 30 μg/mL of MPS, or a combination of AREG and MPS. Data represent the mean ± SD (n = 3). *p < 0.05 versus untreated control (Dunnett's multiple comparison test), #p < 0.05 versus AREG-treated (Aspin-Welch's t-test). (c) A heatmap showing the expression of 4150 DEGs from the monolayer culture experiment (Figure 1) in keratinocytes subjected to the aforementioned treatments. The colour scale represents the scaled expression of each gene. (d) Enrichment plots from GSEA of DEGs in keratinocytes treated with AREG antibody, compared to untreated controls. Top 200 upregulated or downregulated genes from the monolayer culture experiment (Figure 1) were utilised as gene sets. P denotes p value, NES denotes the normalised enrichment score. (e) Relative expression of representative genes in keratinocytes, as determined by real-time qPCR. These keratinocytes were treated with MPS at concentrations ranging from 3 to 300 μg/mL for 24 h, or untreated, in the presence of various EGFR-ligands. The concentrations of the EGFR- ligands were as follows: EGF at 3 ng/mL, <t>HBEGF</t> at 10 ng/mL, AREG at 300 ng/mL, and EPGN at 1000 ng/mL. Data represent the mean ± SD (n = 3). DEG, differentially expressed gene; GSEA, gene set enrichment analysis; MPS, mucopolysacccharide polyphosphate; TPM, transcripts per million.
    Heparinbinding Egf Like Growth Factor, supplied by OriGene, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+hbegf/HB+EGF+(HBEGF)+(NM_001945)+Human+Recombinant+Protein/pm37029764-92-30-34
    Average 91 stars, based on 1 article reviews
    heparinbinding egf like growth factor - by Bioz Stars, 2026-09
    91/100 stars
      Buy from Supplier

    90
    PeproTech recombinant human hbegf
    FIGURE 3 | MPS induced perturbations similar to those resulting from AREG inhibition. (a) A bar chart showing the TPM levels of seven known EGFR-ligands in untreated monolayer-cultured keratinocytes. Data represent the mean ± SD (n = 3). (b) A bar chart showing the first principal component value from PCA of bulk RNA-seq data from keratinocytes, subjected to various treatments for 24 h: 50 μg/mL of AREG antibody (AREG_Ab), 300 ng/ mL of AREG, 30 μg/mL of MPS, or a combination of AREG and MPS. Data represent the mean ± SD (n = 3). *p < 0.05 versus untreated control (Dunnett's multiple comparison test), #p < 0.05 versus AREG-treated (Aspin-Welch's t-test). (c) A heatmap showing the expression of 4150 DEGs from the monolayer culture experiment (Figure 1) in keratinocytes subjected to the aforementioned treatments. The colour scale represents the scaled expression of each gene. (d) Enrichment plots from GSEA of DEGs in keratinocytes treated with AREG antibody, compared to untreated controls. Top 200 upregulated or downregulated genes from the monolayer culture experiment (Figure 1) were utilised as gene sets. P denotes p value, NES denotes the normalised enrichment score. (e) Relative expression of representative genes in keratinocytes, as determined by real-time qPCR. These keratinocytes were treated with MPS at concentrations ranging from 3 to 300 μg/mL for 24 h, or untreated, in the presence of various EGFR-ligands. The concentrations of the EGFR- ligands were as follows: EGF at 3 ng/mL, <t>HBEGF</t> at 10 ng/mL, AREG at 300 ng/mL, and EPGN at 1000 ng/mL. Data represent the mean ± SD (n = 3). DEG, differentially expressed gene; GSEA, gene set enrichment analysis; MPS, mucopolysacccharide polyphosphate; TPM, transcripts per million.
    Recombinant Human Hbegf, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+hbegf/hbegf/pm35995102-57-0-9
    Average 90 stars, based on 1 article reviews
    recombinant human hbegf - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    FIGURE 3 | MPS induced perturbations similar to those resulting from AREG inhibition. (a) A bar chart showing the TPM levels of seven known EGFR-ligands in untreated monolayer-cultured keratinocytes. Data represent the mean ± SD (n = 3). (b) A bar chart showing the first principal component value from PCA of bulk RNA-seq data from keratinocytes, subjected to various treatments for 24 h: 50 μg/mL of AREG antibody (AREG_Ab), 300 ng/ mL of AREG, 30 μg/mL of MPS, or a combination of AREG and MPS. Data represent the mean ± SD (n = 3). *p < 0.05 versus untreated control (Dunnett's multiple comparison test), #p < 0.05 versus AREG-treated (Aspin-Welch's t-test). (c) A heatmap showing the expression of 4150 DEGs from the monolayer culture experiment (Figure 1) in keratinocytes subjected to the aforementioned treatments. The colour scale represents the scaled expression of each gene. (d) Enrichment plots from GSEA of DEGs in keratinocytes treated with AREG antibody, compared to untreated controls. Top 200 upregulated or downregulated genes from the monolayer culture experiment (Figure 1) were utilised as gene sets. P denotes p value, NES denotes the normalised enrichment score. (e) Relative expression of representative genes in keratinocytes, as determined by real-time qPCR. These keratinocytes were treated with MPS at concentrations ranging from 3 to 300 μg/mL for 24 h, or untreated, in the presence of various EGFR-ligands. The concentrations of the EGFR- ligands were as follows: EGF at 3 ng/mL, HBEGF at 10 ng/mL, AREG at 300 ng/mL, and EPGN at 1000 ng/mL. Data represent the mean ± SD (n = 3). DEG, differentially expressed gene; GSEA, gene set enrichment analysis; MPS, mucopolysacccharide polyphosphate; TPM, transcripts per million.

    Journal: Experimental dermatology

    Article Title: Pharmacological Impacts of Mucopolysacccharide Polyphosphates in the Epidermis Involves Inhibition of Amphiregulin-Mediated Signals in Keratinocytes.

    doi: 10.1111/exd.70000

    Figure Lengend Snippet: FIGURE 3 | MPS induced perturbations similar to those resulting from AREG inhibition. (a) A bar chart showing the TPM levels of seven known EGFR-ligands in untreated monolayer-cultured keratinocytes. Data represent the mean ± SD (n = 3). (b) A bar chart showing the first principal component value from PCA of bulk RNA-seq data from keratinocytes, subjected to various treatments for 24 h: 50 μg/mL of AREG antibody (AREG_Ab), 300 ng/ mL of AREG, 30 μg/mL of MPS, or a combination of AREG and MPS. Data represent the mean ± SD (n = 3). *p < 0.05 versus untreated control (Dunnett's multiple comparison test), #p < 0.05 versus AREG-treated (Aspin-Welch's t-test). (c) A heatmap showing the expression of 4150 DEGs from the monolayer culture experiment (Figure 1) in keratinocytes subjected to the aforementioned treatments. The colour scale represents the scaled expression of each gene. (d) Enrichment plots from GSEA of DEGs in keratinocytes treated with AREG antibody, compared to untreated controls. Top 200 upregulated or downregulated genes from the monolayer culture experiment (Figure 1) were utilised as gene sets. P denotes p value, NES denotes the normalised enrichment score. (e) Relative expression of representative genes in keratinocytes, as determined by real-time qPCR. These keratinocytes were treated with MPS at concentrations ranging from 3 to 300 μg/mL for 24 h, or untreated, in the presence of various EGFR-ligands. The concentrations of the EGFR- ligands were as follows: EGF at 3 ng/mL, HBEGF at 10 ng/mL, AREG at 300 ng/mL, and EPGN at 1000 ng/mL. Data represent the mean ± SD (n = 3). DEG, differentially expressed gene; GSEA, gene set enrichment analysis; MPS, mucopolysacccharide polyphosphate; TPM, transcripts per million.

    Article Snippet: After HEKa cells had been seeded on cell culture plates at a density of 5.6 × 104 cells/cm2 and incubated for 24 h, then they were incubated with or without MPS (Maruho, Osaka, Japan), recombinant human amphiregulin (R&D systems, Minneapolis, MN, USA), human amphiregulin antibody (R&D systems), recombinant human EGF (R&D systems), recombinant human HBEGF (R&D systems), recombinant human EREG (R&D systems), in HuMedia- KB2 (Kurabo Industries) for 24 h at 37°C.

    Techniques: Inhibition, Cell Culture, RNA Sequencing, Control, Comparison, Expressing